Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dragoneer Investment Group

Investor type Private Equity Firm
Founders Marc Stad


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 177
Average round size
The average size of a deal this fund participated in
Portfolio companies 118
Rounds per year 17.70
Lead investments 15
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 29
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Software
  • FinTech
  • SaaS
  • Financial Services
  • E-Commerce

The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the San Francisco.

The real fund results show that this Corporate Investor is 14 percentage points more often commits exit comparing to other companies. When the investment is from Dragoneer Investment Group the average startup value is more than 1 billion dollars. The important activity for fund was in 2019. The top amount of exits for fund were in 2018. Comparing to the other companies, this Dragoneer Investment Group performs on 8 percentage points more the average number of lead investments. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is generally included in 7-12 deals every year.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Logistics, FinTech. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Alibaba, Uber, Snap

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Dragoneer Investment Group, startups are often financed by Sequoia Capital, Index Ventures, Tiger Global Management. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital, Coatue Management, Tiger Global Management. In the next rounds fund is usually obtained by Tiger Global Management, T. Rowe Price, DST Global.

This organization was formed by Marc Stad. Besides them, we counted 1 critical employee of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Dragoneer Investment Group:
Typical Co-investors
Dragoneer Investment Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Dragoneer Investment Group:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alpha Investments India, Maharashtra, Mumbai
Deutsche Kreditbank Berlin, Berlin, Germany
Formula Systems Israel, Or Yehuda, Tel Aviv
Fort Rock Capital England, London, United Kingdom
KPN Ventures Rotterdam, The Netherlands, Zuid-Holland
Kunlun Trust China, Ningbo, Zhejiang
Lurra Capital -
Metaconstant Ventures -
Milar Ventures -
Moai Capital California, San Mateo, United States
Piramal Capital & Housing Finance India, Maharashtra, Mumbai
Piva Capital California, San Francisco, United States
Qantas Loyalty -
Qianhai Hesheng Tianshi Touzi China, Guangdong, Shenzhen
RCI Bank and Services France, Ile-de-France, Paris
Shanghai Jiahe Zhubao China, Minhang, Shanghai
TIU Fund -
Trivergance Fort Lee, New Jersey, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Maven Clinic

Health Care
Health Diagnostics
Personal Health
$90M14 Nov 2022 New York, New York, United States


Artificial Intelligence
Autonomous Vehicles
Computer Vision
Machine Learning
Real Estate
$167M15 Jun 2022 Los Angeles, California, United States


Digital Marketing
Loyalty Programs
Marketing Automation
Point of Sale
Transaction Processing
$300M18 May 2022 San Francisco, California, United States


Financial Exchanges
$170M11 May 2022 New York, New York, United States


Health Care
Health Insurance
$215M04 May 2022 Paris, Ile-de-France, France

Reify Health

Business/Productivity Software
Clinical Trials
Health Care
Other Healthcare Services
Other Healthcare Technology Systems
$220M21 Apr 2022 Boston, Massachusetts, United States


Oil and Gas
$50M12 Apr 2022 Houston, Texas, United States

Bazaar Technologies

$70M14 Mar 2022 Karachi, Sindh, Pakistan


Financial Services
$137M06 Mar 2022 Chennai, Tamil Nadu, India
Zerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions

– Zerigo Health announced a $43m Series B investment led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, and Leaps by Bayer.
– The round also included participation by existing investors including SV Health Investors, H.I.G. Capital, and Bluestem Capital.
– This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.
– Glen Tullman, Managing Partner of 7wireVentures, former Founder and CEO of Livongo, and Chief Executive Officer of Transcarent, will join as Executive Chairman of the company’s Board of Directors.

Cannabis tech startup Dutchie raises $350M to double valuation to $3.75B in less than a year

– Dutchie, a technology company that helps facilitate legal cannabis orders, raised $350m in Series D funding.
– The round was led by D1 Capital Partners, with participation from previous investors including Tiger Global, Dragoneer, DFJ Growth, Thrive Capital, Gron Ventures, and Casa Verde Capital, and new investors, including Willoughby Capital, Glynn Capital, and Park West Asset Management.
– It brings the company to a valuation of $3.75 billion.
– The company’s technology includes e-commerce, point of sale and seamless payment solutions and is used to power annual sales of more than $14 billion at 5,000 cannabis dispensaries across North America.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dragoneer Investment Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: